Key result
The 9p21 variant is linked to ~2-fold higher CAD risk in premature heart disease.
Why the study?
The role of genetic risk factors in the management of coronary artery disease is yet to be determined, despite identification of multiple risk variants.
The identification of 50 genetic risk variants for CAD, many of which operate independently of known risk factors, suggests that genetic risk profiling may need to be incorporated into future clinical guidelines for risk stratification and lipid management.
No takes yet. Share an insight, caveat, or question.
9p21 identifies elevated CAD risk independent of traditional factors; leaves open its integration into clinical risk models pending prospective validation.
Robert Roberts (2014) conducted a review in Coronary artery disease. Genetic risk variants (e.g., 9p21) was evaluated. The 9p21 genetic variant increases the risk of coronary artery disease twofold in individuals with premature heart disease, and by 25% to 50% in the overall population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: